QLGN vs SHPH

Comparison between Qualigen Therapeutics, Inc. Common Stock (QLGN, Company) and Shuttle Pharmaceuticals Holdings Inc (SHPH, Company).

Both QLGN and SHPH are from the Healthcare sector.

QLGN vs SHPH - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	QLGN(COMPANY)	SHPH(COMPANY)
Market Cap	$2.09M	$2.05M
Max Drawdown	100.00%	100.00%
Sharpe Ratio	-0.20	-1.14
5Y Beta	N/A	0.00
Industry	Biotechnology	Drug Manufacturers - Specialty & Generic
P/E Ratio	-0.44	-0.05
Debt to Equity	8.40%	0.00%
P/S Ratio	1.12	N/A
P/B Ratio	0.05	N/A

Market Cap

Winner

QLGN

$2.09M

SHPH

$2.05M

Max Drawdown

QLGN

100.00%

Winner

SHPH

100.00%

Sharpe Ratio

Winner

QLGN

-0.20

SHPH

-1.14

5Y Beta

QLGN

N/A

SHPH

0.00

Industry

QLGN

Biotechnology

SHPH

Drug Manufacturers - Specialty & Generic

P/E Ratio

Winner

QLGN

-0.44

SHPH

-0.05

Debt to Equity

QLGN

8.40%

Winner

SHPH

0.00%

P/S Ratio

QLGN

1.12

SHPH

N/A

P/B Ratio

QLGN

0.05

SHPH

N/A

QLGN vs SHPH - Historical Returns

Returns include dividend reinvestment.

Period	QLGN	SHPH
1 month	-7.75%	-36.63%
3 months	-9.85%	-60.67%
6 months	-55.93%	-79.50%
1 year	-66.67%	-89.34%
5 years(CAGR)	-74.27%	N/A
10 years(CAGR)	-70.16%	N/A
Max(CAGR)	-69.78%	-92.63%

Winner

QLGN

-7.75%

SHPH

-36.63%

Winner

QLGN

-9.85%

SHPH

-60.67%

Winner

QLGN

-55.93%

SHPH

-79.50%

Winner

QLGN

-66.67%

SHPH

-89.34%

5Y(CAGR)

QLGN

-74.27%

SHPH

N/A

10Y(CAGR)

QLGN

-70.16%

SHPH

N/A

Max(CAGR)

Winner

QLGN

-69.78%

SHPH

-92.63%

QLGN vs SHPH - Annual Returns (2015 - 2026)

Returns include dividend reinvestment.

Year	QLGN	SHPH
2026	-50.42%	-79.61%
2025	-44.30%	-91.54%
2024	-84.80%	-78.71%
2023	-60.14%	-74.72%
2022	-89.08%	-94.91%
2021	-66.03%	N/A
2020	-41.84%	N/A
2019	-79.81%	N/A
2018	-80.77%	N/A
2017	-88.62%	N/A
2016	+66.26%	N/A
2015	-65.73%	N/A